NCT06754085View on ClinicalTrials.gov

Study of 18F-Florastamin PET/CT Imaging in Patients With Suspected Recurrence of Prostate Cancer

PHASE3RecruitingINTERVENTIONAL

Enrollment

131

Participants

Timeline

Start Date

December 19, 2024

Primary Completion Date

January 1, 2026

Study Completion Date

May 1, 2026

Conditions

Prostate Cancer

Interventions

DRUG

Florastamin[18F] Injection

The subjects will be intravenously injected with a single dose of 7±1 mCi (259±37 MBq) of Florastamin\[18F\] Injection and undergo PET/CT scan at 60-110 min after the injection.

Trial Locations (1)

Unknown

RECRUITING

Sun Yat-sen University Cancer Center, Guangzhou

All Listed Sponsors

lead

HTA Co., Ltd.

INDUSTRY